Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)

Background

Some patients with refractory asthma have evidence of uncontrolled eosinophilic inflammation in the distal airways. While traditional formulations of inhaled steroids settle predominantly in the large airways, newer formulations with an extra-fine particle size have a more peripheral pattern of deposition. Specifically treating distal airway inflammation may improve asthma control.

Methods

30 patients with refractory asthma despite high dose inhaled corticosteroids were identified as having persistent airway eosinophilia. Following 2 weeks of prednisolone 30 mg, patients demonstrating an improvement in asthma control were randomised to receive either ciclesonide 320 µg twice daily or placebo in addition to usual maintenance therapy for 8 weeks. The primary outcome measure was sputum eosinophil count at week 8. Alveolar nitric oxide was measured as a marker of distal airway inflammation.

Results

There was continued suppression of differential sputum eosinophil counts with ciclesonide (median 2.3%) but not placebo (median 4.5%) though the between-group difference was not significant. When patients who had changed their maintenance prednisolone dose during the trial were excluded the difference between groups was significant (1.4% vs 4.5%, p=0.028). Though alveolar nitric oxide decreased with ciclesonide the value did not reach statistical significance.

Conclusions

These data demonstrate that patients with ongoing eosinophilic inflammation are not truly refractory, and that suppression of airway eosinophilia may be maintained with additional inhaled corticosteroid. Further work is needed with a focus on patient-orientated outcome measures such as exacerbation rate, with additional tests of small airway function.

Trial registration number

NCT01171365. Protocol available at http://www.clinicaltrials.gov.

Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults

The 2015 British Thoracic Society (BTS) Home Oxygen Guidelines provides detailed evidence-based guidance for the use of oxygen by patients in their own homes or other non-acute hospital settings.

Developmental determinants in non-communicable chronic diseases and ageing

Prenatal and peri-natal events play a fundamental role in health, development of diseases and ageing (Developmental Origins of Health and Disease (DOHaD)). Research on the determinants of active and healthy ageing is a priority to: (i) inform strategies for reducing societal and individual costs of an ageing population and (ii) develop effective novel prevention strategies. It is important to compare the trajectories of respiratory diseases with those of other chronic diseases.

Non-coding RNAs in the pathogenesis of COPD.

Related Articles

Non-coding RNAs in the pathogenesis of COPD.

Thorax. 2015 May 20;

Authors: De Smet EG, Mestdagh P, Vandesompele J, Brusselle GG, Bracke KR

Abstract
A large part of the human genome is transcribed in non-coding RNAs, transcripts that do not code for protein, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). MiRNAs are short single-stranded RNA molecules that negatively regulate gene expression at the post-transcriptional level. They play an important regulatory role in many biological processes. Consequently, altered expression of these non-coding RNAs has been shown to lead to inflammation and disease. In contrast, lncRNAs, can both enhance or repress the expression of protein-coding genes. COPD is typically caused by tobacco smoking and leads to a progressive decline in lung function and a premature death. Exaggerated pulmonary inflammation is a hallmark feature in this disease, leading to obstructive bronchiolitis and emphysema. In this review, we discuss the miRNA expression patterns in lungs of patients with COPD and in mouse models and we highlight various miRNAs involved in COPD pathogenesis. In addition, we briefly discuss a specific lncRNA that is upregulated upon cigarette smoke exposure, providing a short introduction to this more recently discovered group of non-coding RNAs.

PMID: 25995155 [PubMed - as supplied by publisher]

Longitudinal changes in hand grip strength, hyperinflation and 6-minute walk distance in COPD patients and a control group.

Related Articles

Longitudinal changes in hand grip strength, hyperinflation and 6-minute walk distance in COPD patients and a control group.

Chest. 2015 May 21;

Authors: Cortopassi F, Celli B, Divo M, Pinto-Plata V

Abstract
Introduction: In chronic obstructive pulmonary disease (COPD), a decreased inspiratory/total lung capacity ratio (IC/TLC), is associated with dynamic hyperinflation (DH) and poor exercise capacity. The association to upper extremity force measured by handgrip strength (HGS) and 6 minute walk distance has not been described. We hypothesized that IC/TLC affects muscle strength of upper and lower extremities affecting HGS and the six minute walk test (6MWD) performance.
Methods: We prospectively measured lung function, HGS and 6MWD in 27 patients with COPD and 12 healthy nonsmoking individuals twice, 1 year apart. The patients were classified according to level of hyperinflation in 2 groups, IC/TLC > or ≤ 25%.
Results: Patients with COPD had reduced lung function, static hyperinflation, reduced HGS and 6MWD compared to the controls on both evaluations (p < 0.01). There was a statistically significant deterioration in HGS, IC/TLC and 6MWD after 1 year follow up in the COPD compared to the control group (p < 0.001). More hyperinflation (IC/TLC < .25) was associated with lower HGS and 6MWD (p < 0.001). Changes in IC/TLC correlated with changes in HGS (r = 0.429, p < 0.05). A multivariate analysis determined that IC/TLC was an independent factor associated to HSG and to 6MWD.
Conclusion: Handgrip strength and 6MWD are reduced in patients with COPD, particularly in patients with hyperinflation with evidence of longitudinal deterioration not seen in controls. This suggests that resting hyperinflation may exert a detrimental effect on cardiac function and play a role in the reduced exercise performance in COPD patients.

PMID: 25996450 [PubMed - as supplied by publisher]

Search